| 000 | 01243 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511214009.0 | ||
| 264 | 0 | _c19920108 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1991.tb03931.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBroly, F | |
| 245 | 0 | 0 |
_aThe metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cOct 1991 |
||
| 300 |
_a459-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDebrisoquin _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMexiletine _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aSmoking _xmetabolism |
| 650 | 0 | 4 |
_aSparteine _xmetabolism |
| 700 | 1 | _aVandamme, N | |
| 700 | 1 | _aLibersa, C | |
| 700 | 1 | _aLhermitte, M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 32 _gno. 4 _gp. 459-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1991.tb03931.x _zAvailable from publisher's website |
| 999 |
_c1964626 _d1964626 |
||